Flavivirus sfRNA suppresses antiviral RNA interference in cultured cells and mosquitoes and directly interacts with the RNAi machinery  by Moon, Stephanie L. et al.
Flavivirus sfRNA suppresses antiviral RNA interference in cultured cells
and mosquitoes and directly interacts with the RNAi machinery
Stephanie L. Moon, Benjamin J.T. Dodd, Doug E. Brackney 1, Carol J. Wilusz, Gregory D. Ebel,
Jeffrey Wilusz n
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA
a r t i c l e i n f o
Article history:
Received 20 February 2015
Returned to author for revisions
7 August 2015
Accepted 9 August 2015









a b s t r a c t
Productive arbovirus infections require mechanisms to suppress or circumvent the cellular RNA
interference (RNAi) pathway, a major antiviral response in mosquitoes. In this study, we demonstrate
that two ﬂaviviruses, Dengue virus and Kunjin virus, signiﬁcantly repress siRNA-mediated RNAi in
infected human cells as well as during infection of the mosquito vector Culex quinquefasciatus.
Arthropod-borne ﬂaviviruses generate a small structured non-coding RNA from the viral 30 UTR referred
to as sfRNA. Analysis of infections with a mutant Kunjin virus that is unable to generate appreciable
amounts of the major sfRNA species indicated that RNAi suppression was associated with the generation
of the non-coding sfRNA. Co-immunoprecipitation of sfRNAwith RNAi mediators Dicer and Ago2 suggest
a model for RNAi suppression. Collectively, these data help to establish a clear role for sfRNA in RNAi
suppression and adds to the emerging impact of viral long non-coding RNAs in modulating aspects of
anti-viral immune processes.
& 2015 Elsevier Inc. All rights reserved.
Introduction
RNA interference (RNAi) is a major pathway of antiviral defense
in plants and insects (Pumplin and Voinnet, 2013; Kingsolver et al.,
2013). The pathway involves the processing of double-stranded RNA
(dsRNA) into short 21–22 bp effector RNA molecules by the RNAse
III domain-containing Dicer 2 enzyme (Ipsaro and Joshua-Tor, 2015).
The ﬁdelity of Dicer cleavage and downstream strand selection in
the RNAi process is maintained by Dicer-associated proteins (TRBP
and PACT in mammalian cells) (Heyam et al., 2015). These dsRNA
serve as targeting moieties when loaded into a RISC complex to
selectively downregulate mRNA targets. Argonaute proteins (e.g.
Ago2) play a major role in the knockdown of gene expression by the
RISC complex, mediating selective endonucleolytic cleavage of
target RNAs (Dueck and Meister, 2014). The successful avoidance
or downregulation of the RNAi machinery is vital for arboviruses to
productively infect their arthropod vectors.
Flaviviruses are single-stranded positive-sense RNA viruses that
cause a variety of signiﬁcant human diseases. Many members of
this family are arboviruses, using arthropod vectors (primarily
mosquitoes) as a key part of their transmission cycles. The Dengue
viruses (DENV), West Nile virus (WNV), and Japanese Encephalitis
virus (JEV) are examples of ﬂaviviruses with a major impact on
human health (Go et al., 2014). The ﬂavivirus genomic RNA
contains a single large polyprotein-encoding open reading frame
ﬂanked by untranslated regions (UTR). Interestingly, a small
subgenomic ﬂavivirus RNA (sfRNA) which represents the 30 UTR
of the viral genomic RNA, is generated not by a subgenomic
promoter but rather by stalling of the cellular 50–30 exoribonu-
clease XRN1 as it tries to degrade viral positive-sense transcripts
(Pijlman et al., 2008; Funk et al., 2010; Silva et al., 2010; Chapman
et al., 2014a, 2014b). Thus in addition to the individual structural
and non-structural proteins that are made by the virus, large
amounts of this non-coding sfRNA also accumulate in infected
cells. The generation of sfRNA has been previously associated with
repression of the XRN1 enzyme and stabilization of mRNAs in
infected cells (Moon et al., 2012) as well as a sponge for a set of
cellular proteins involved in translational regulation of interferon-
stimulated mRNAs (Schuessler et al., 2012; Chang et al., 2013;
Bidet et al., 2014). Given the increasing appreciation for the major
roles played by cellular non-coding transcripts (including regulat-
ing the responses to viral infections (Gomez et al., 2013; Ouyang
et al., 2014)), it is perhaps not surprising that ﬂaviviruses would
also generate a multi-functional non-coding RNA that has a major
impact on the outcome of infections.
Many viruses encode RNAi suppressors that down-regulate this
arm of the host cell antiviral response and promote efﬁcient viral
replication (Szittya and Burgyán, 2013; van Mierlo et al., 2014).
Most characterized RNAi suppressors are proteins that bind and
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sequester dsRNA. Examples of insect virus-encoded RNAi suppres-
sors include the dsRNA binding proteins B2 of ﬂock house virus
(Chao et al., 2005), 1A of Drosophila C virus (van Rij et al., 2006),
the VP3 proteins of Drosophila X virus and Culex Y virus (van Cleef
et al., 2014), and 340R of invertebrate iridescent virus 6
(Bronkhorst et al., 2014). Alternatively, RNAi suppressor proteins
can act by directly interacting with RNAi effector proteins. Exam-
ples of this strategy in insect viruses include the 1A protein of
Cricket paralysis virus (Nayak et al., 2010) and the Vp1 protein of
Nora virus (van Mierlo et al., 2012). Both of these proteins bind to
the effector protein AGO2 and antagonize its enzymatic activity.
Interestingly, the Nora virus Vp1 proteins can show host-speciﬁc
preferences in AGO2 suppression that may reﬂect rapid co-
evolution of host and viral RNAi-associated factors (van Mierlo
et al., 2014). RNA-mediated suppression of RNAi was ﬁrst docu-
mented in cells by analysis of adenoviral VA1 RNA (Lu and Cullen,
2004). Finally, using viral replicons, ﬂavivirus sfRNA has also been
implicated as an RNAi suppressor in non-human primate and
mosquito cells in culture (Schnettler et al., 2012). However, the
biological relevance of these ﬁndings during a natural infection, as
well as the mechanism of the suppression, are unclear.
In this study we wished to conﬁrm and expand upon observa-
tions that sfRNA is an RNAi suppressor (Schnettler et al., 2012).
Using viral infections, we demonstrate a mild but statistically
signiﬁcant suppression of siRNA-mediated RNAi in both Dengue
virus type 2 (DENV-2) and KUNV infected human cells. Impor-
tantly, dsRNA-mediated knockdown of gene expression was also
suppressed in live mosquitoes that were infected by KUNV. The
suppression of RNAi in KUNV infections in both tissue culture and
mosquitoes was dependent on the generation of sfRNA, as a viral
variant that fails to generate the major species of sfRNA also failed
to suppress RNAi. Finally, we demonstrated a direct interaction
between sfRNA sequences and both Dicer and AGO2 host cell
proteins, providing important insights into the potential under-
lying mechanism of RNAi suppression.
Results
Dengue virus type 2 and Kunjin virus infections suppress siRNA-
mediated knockdown in human cells
Viral encoded suppressors of RNAi can play a major role during
RNA virus infection of plants and insects where RNAi-mediated
antiviral defense is a major host response to the accumulation of
viral RNAs. Previous work using WNV and DENV-1 replicons has
suggested that rather than virally encoded proteins, the sfRNA
generated from the 30 UTR during ﬂavivirus infection serves as a
mild suppressor of RNAi in Vero and Aedes albopictus U4.4 cells
(Schnettler et al., 2012). In order to extend these observations to
bona ﬁde viral infections, we infected human 293T cells with
DENV-2 (Jamaica 1409) and assessed the efﬁcacy of siRNA-directed
RNAi. As seen in Fig. 1A, copious amounts of sfRNA was produced
at 4 dpi as expected from previous observations (Moon et al.,
2012). The major sfRNA species was 420 nts – and additional
minor sfRNA species of shorter size were also observed. This is
consistent with previous reports of additional structured regions
in the DENV-2 30 UTR and a small amount of XRN1 exonuclease
passing through the 50-most knot-like structure described pre-
viously (Chapman et al., 2014a, 2014b). To assess the relative
efﬁcacy of RNAi during DENV-2 infection, mock or DENV-2
infected 293T cells were transfected with an eGFP expressing
reporter construct in the presence or absence of an eGFP mRNA-
speciﬁc siRNA. As seen in Fig. 1B, eGFP mRNA was efﬁciently
expressed in the absence of siRNA in both mock and DENV-2-
infected 293T cells. While siRNA to eGFP effectively knocked down
eGFP mRNA expression in mock infected cells, siRNA knockdown
in DENV-2-infected cells was 2.5-fold less efﬁcient (po0.05).
GAPDH was used as an internal control/reference gene to account
for any differences in total mRNA abundance. Note also that the
increase in eGFP levels observed in DENV infection (Fig. 1B) was
taken into account in deriving siRNA knockdown efﬁciency by
normalizing the eGFP abundances in the DENV infected, siRNA-
transfected sample to eGFP abundance in the DENV infected, ‘no
siRNA’ controls. We believe that the reproducibly observed
increased levels of eGFP mRNA levels during ﬂavivirus infection
are due to XRN1 suppression by sfRNA and subsequent stabiliza-
tion of cellular mRNAs that we previously reported (Moon et al.,
2012). Since sfRNA is present in both siRNA containing and no-
siRNA control DENV-2 infected samples, a valid comparison of
siRNA knockdown efﬁciency could be obtained despite the overall
increase in eGFP mRNA levels likely due to repression of XRN1-
mediated RNA decay. Furthermore, repression of XRN1 activity
(using siRNA knockdown) failed to have any effect on the efﬁ-
ciency of siRNAs to target and knock down the eGFP reporter
mRNAs (Fig. S1).
These observations were extended to infection of human 293T
cells with another ﬂavivirus, KUNV, which also produces sfRNA
during infection (Fig. 2A). While eGFP mRNA was effectively
knocked down by siRNA transfection in mock-infected cells,
siRNA-mediated knockdown of eGFP mRNA expression was 3-
fold less efﬁcient in KUNV-infected cells (Fig. 2B; po0.05).
Importantly, a variant of KUNV containing mutations in the 30
UTR and cannot generate detectable amounts of the major sfRNA
species (Fig. 2A) also failed to effectively suppress RNAi-
knockdown of the eGFP reporter mRNA by targeted siRNAs
(Fig. 2B) (Pijlman et al., 2008). As performed for DENV-2 infections
Fig. 1. siRNA-mediated knockdown of a reporter eGFP RNA is suppressed in DENV-
2 infected 293T cells. Panel A: A representative northern blot of total RNA from
mock infected or DENV-2 infected 293T cells at 4 dpi (MOI of 3) probing for the
viral 30 UTR. The most abundant sfRNA species is denoted by the arrow. Panel B: A
representative northern blot to detect the eGFP mRNA in 293T cells transfected
with peGFP-N1 with or without an siRNA to the eGFP mRNA at 3 dpi with DENV-2.
Total RNA was collected at 4 dpi, residual DNA was removed, and RNA separated on
a denaturing agarose gel. The 18S rRNA was visualized by ethidium bromide
staining prior to transfer as a loading control. The graph on the right shows
quantiﬁcation of the relative suppression of eGFP siRNA-mediated knockdown in
mock infected or DENV-2 infected cells was done by qRT-PCR using primers that
spanned the siRNA cleavage site in the eGFP mRNA and GAPDH as a reference gene.
The Y axis reﬂects the abundance of eGFP mRNA in the cells that received siRNA to
eGFP relative to the eGFP abundance in the cells that did not receive siRNA to eGFP.
The average7standard deviation of two independent experiments is shown with *
indicating po0.05 by Student's t-test.
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described above, GAPDH was used as a reference gene to account
for small differences in mRNA abundance in each sample. Further-
more, the increase in eGFP levels observed in KUNV infection
(Fig. 2B) was taken into account in deriving siRNA knockdown
efﬁciency by normalizing the eGFP abundances in the siRNA-
transfected sample to eGFP abundance in ‘no siRNA’ controls for
both mock and KUNV-infected cells. Notably, the sfRNA(-)KUNV
variant replicated to similar levels as wild-type KUNV virus in
293T cells as assessed by qRT-PCR analyses of intracellular viral
RNA levels (Moon et al., 2012). As stated above, the reproducibly
observed increase in the levels of eGFP mRNA during KUNV
infection are very likely due to XRN1 suppression by sfRNA and
subsequent stabilization of cellular mRNAs that we reported
previously (Moon et al., 2012).
Therefore we conclude that RNAi is mildly but signiﬁcantly
suppressed during either DENV-2 or KUNV infection of human
cells. Further, consistent with a previous report (Schnettler et al.,
2012), the suppression of RNAi is closely associated with sfRNA
production. Flaviviral sfRNA was capable of repressing siRNA-
mediated RNAi, implying that the small RNA is capable of inter-
fering with the loading of siRNAs into the RISC complex.
KUNV suppresses RNAi in mosquito infection in an sfRNA-dependent
fashion
While data from tissue culture infections indicates that ﬂavi-
virus infections can partially suppress an RNAi response, a key
question that remains to be answered is whether a similar effect
can be observed during infections of whole mosquitoes. To address
this, Culex quinquefasciatus mosquitoes were infected with either
wild type KUNV or the sfRNA(-)KUNV variant. At 7 dpi, a dramatic
accumulation of sfRNA was observed by northern blot of total RNA
derived fromwhole body samples while no sfRNA was observed in
total RNA derived from sfRNA-KUNV variant viral infections
(Fig. 3A). Importantly, as assayed by RT-qPCR with primers to the
viral open reading frame, the amount of viral genomic RNA in
these whole body RNA samples did not differ signiﬁcantly
between wild type and sfRNA(-) KUNV infections (Fig. 3B). Thus,
as expected, in sfRNA(-) KUNV infections there was a speciﬁc
defect in the accumulation of the small structured 30 UTR-derived
RNA that was not a result of an overall reduction in viral genomic
RNA accumulation.
In order to assess the inﬂuence of KUNV sfRNA expression on
the efﬁciency of RNAi activity in infected mosquitoes, dsRNA
Fig. 2. siRNA-mediated mRNA knockdown is inhibited in KUNV infections in an
sfRNA-dependent manner. Panel A: A representative northern blot showing the
accumulation of sfRNA at 60 hpi in wild-type KUNV infected 293T cells but not in
mock-infected or sfRNA(-) KUNV infected cells. The arrow denotes the most
abundant sfRNA species. Panel B: A representative northern blot using puriﬁed
total RNA from mock infected, wild-type or sfRNA(-) KUNV infected 293T cells at 60
hpi is shown. 293T cells were infected and transfected with peGFP-N1 with or
without siRNA to the eGFP mRNA using a probe to the eGFP mRNA. The 18S rRNA
detected by ethidium bromide staining was used as a loading control before RNA
transfer to nylon membranes. Graph on the right side of the panel: cells were either
mock treated or infected with the indicated KUNV isolate and a quantitative
assessment of eGFP mRNA abundance in siRNA-treated cells compared to cells
transfected with peGFP-N1 alone was done by RT-qPCR using primers that span the
eGFP siRNA target site and GAPDH as a reference gene. The average of two
independent infections is presented with standard deviation and Student's t-test
depicts signiﬁcance with * indicating po0.05.
Fig. 3. RNAi activity is suppressed in Culex quinquefascitus mosquitoes infected
with KUNV in an sfRNA-dependent fashion. Panel A: sfRNA accumulation in
mosquitoes infected with wild-type KUNV but not sfRNA(-) KUNV as detected by
northern blotting with a probe spanning the viral 30 UTR. Each lane received 2.5 μg
total RNA from pools of 3 or more whole bodies of C. quinquefasciatus fed with
blood alone or blood containing 1107 PFU/mL of virus, collected at 8 dpi. A
representative blot is shown with the arrow indicating the major sfRNA species.
Panel B: Relative KUNV RNA abundance in 19 individually collected whole bodies of
blood-fed (1107 PFU/mL KUNV or sfRNA(-) KUNV) C. quinquefasciatus at 8 dpi
determined by RT-qPCR using primers to the viral open reading frame and RPL8 as a
reference gene. The average7standard deviation is shown with Student's t-test
used to determine signiﬁcance (NSD¼not signiﬁcantly different). Panel C: C.
quinquefasciatus mosquitoes were fed blood alone or 1107 PFU/mL KUNV or
sfRNA(-) KUNV and injected with dsRNAs to either a control luciferase mRNA or the
endogenous mosquito transcript chymotrypsin (CHYMO) 7 days later. At 9 days
post-infection (2 days post-injection) mosquitoes were pooled (3 or more per pool),
RNA was extracted and analyzed by RT-qPCR for CHYMO abundance in mosquitoes
that received the CHYMO dsRNA relative to mosquitoes that received the luciferase
dsRNA using GADPH as a reference gene. The above plot depicts results from
3 independent blood feeds/experiments with each gray marker representing
relative suppression/inhibition of CHYMO mRNA knockdown in a single pool of
mosquitoes normalized to luciferase dsRNA injected controls. Statistics were
performed using the ROUT method (Q¼1%) and t tests. The mean is graphed with
error bars representing the standard deviation.
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against the endogenous mosquito chymotrypsin (CHYMO) mRNA
was injected and the knockdown of the targeted mRNA was
assessed by RT-qPCR analysis relative to control mosquitoes
injected with a dsRNA to luciferase. For these analyses, GAPDH
was used as a reference gene/internal control. As seen in Fig. 3C,
expression of the CHYMO mRNA was reduced to an average of
approximately 10% of control levels in the ten pools of injected
uninfected mosquitoes. The efﬁciency of dsRNA-mediated knock-
down of the CHYMOmRNA in mosquitoes infected with the sfRNA-
KUNV variant was similar to the knockdown efﬁciency of mock-
infected mosquitoes. The dsRNA-mediated knockdown of the
CHYMO mRNA in wild type KUNV infected mosquitoes, however,
was signiﬁcantly less efﬁcient, reaching an average of only 30% of
control levels in the pools of infected mosquitoes that were
assayed. Interestingly, the 3-fold decrease in RNAi efﬁciency
was similar to the levels that were observed in tissue culture.
Therefore we conclude that KUNV-infected C. quinquefasciatus
mosquitoes show a reduced siRNA-mediated RNA response that
is dependent upon sfRNA accumulation.
KUNV sfRNA is associated with and may sequester the RNAi
mediators Dicer and Ago2
In order to gain insight into a possible mechanism for how
sfRNA may partially repress RNAi, we hypothesized that the
structured RNA may be capable of interacting with speciﬁc RNAi
mediators and perhaps sequester and prevent them from func-
tioning effectively in the RNAi pathway. A previous report using
recombinant human Dicer protein suggested that sfRNA may
speciﬁcally target this dsRNA cleaving enzyme (Schnettler et al.,
2012). In order to directly assess this, we performed co-
immunoprecipitation assays in KUNV infected cells using Dicer
antibodies and detected the pull down of any viral RNAs by RT-
PCR. As seen in Fig. 4A, the 30 UTR (and thus presumably sfRNA)
was speciﬁcally enriched in immunoprecipitations using Dicer
antibodies to pulldown Dicer and associated RNAs in KUNV
infected 293T cell lysates. Note that formaldehyde was applied to
cells to cross-link RNA protein complexes prior to extract prepara-
tion and high stringency immunoprecipitation in order to ensure
that the complexes being analyzed were likely to represent bona
ﬁde RNA-protein interactions that occur in infected cells.
The Dicer enzyme, however, is not required for the siRNA-
mediated knock down of gene expression that was the focus of this
study. Therefore we examined whether KUNV sfRNA was capable of
directly interacting with a dsRNA-binding RISC complex component
(Takahashi et al., 2014). As seen in Fig. 4B, the 30 UTR (and thus
presumably sfRNA) was speciﬁcally enriched in immunoprecipita-
tions using AGO2 antibodies to pull down this key RISC component
and associated RNAs in cross-linked KUNV infected 293T cell lysates.
Fig. 4C demonstrates that the co-immunoprecipitation of the 30 UTR
portion of KUNV was signiﬁcant, as another RNA binding protein
(CUGBP1 or CELF1) failed to immunoprecipitate viral transcripts
above the background level of the IgG control.
In summary, we conclude that the highly structured sfRNA is
capable of interacting with the RNAi effectors Dicer and AGO2 in
infected cells. This may provide a mechanistic explanation for the
suppression of RNAi activity observed in DENV-2 and KUNV
infections.
Discussion
The data presented above represent three important observa-
tions regarding the interface between the cellular RNAi pathway
and ﬂaviviruses. First, we demonstrated that siRNA-mediated RNAi
knockdowns in human cells could be suppressed by ﬂavivirus
infection in an sfRNA-dependent fashion. These data build upon
previously published observations (Schnettler et al., 2012), extend-
ing RNAi suppression by sfRNA to the context of a ﬂaviviral
infection. Second, data presented in Fig. 3 above extend sfRNA-
mediated RNAi suppression by KUNV to the context of a C.
quinquefasciatus mosquito infection. This is an important demon-
stration of the phenomenon in the context of an arthropod vector
and is a key step towards establishing the biological relevance of
sfRNA-mediated RNAi suppression. Finally, data in Fig. 4 suggest
that an important aspect of the suppression of RNAi by ﬂaviviruses
may be the interaction between sfRNA and two key RNAi media-
tors – Dicer and AGO2. Collectively, these observations provide a
clearer picture of RNAi suppression by ﬂaviviruses and present
several implications with signiﬁcant impact to ﬂavivirus biology.
Based on the interaction of sfRNA with Dicer and AGO2 that
was revealed by co-immunoprecipitation from infected cell
extracts, we propose a model for sfRNA-mediated RNAi suppres-
sion depicted in Fig. 5. The generation of large amounts of sfRNA
by the XRN1 exoribonuclease stalling at the knot-like structures at
the proximal (50) side of the 30 UTR (Chapman et al., 2014a) allows
Fig. 4. Kunjin virus 30 UTR RNAs are associated with Dicer and Ago2 proteins by co-immunoprecipitation analysis. Antibodies to RNA induced silencing complex components
Dicer (Panel A) or AGO2 (Panel B) were used to co-purify RNA from wild-type KUNV infected 293T cells (60 hpi, MOI of 5) following formaldehyde cross-linking to stabilize
complexes in vivo. Normal rabbit or rat IgG antibodies were used as non-speciﬁc controls. Isolated RNAs were ampliﬁed by RT-PCR using primers to the KUNV open reading
frame upstream of the sfRNA start site (ORF) or to the viral 30 untranslated region (30 UTR) and PCR products were visualized on agarose gels by ethidium bromide staining.
Representative gels are shown. Panel C: Formaldehyde cross-linked lysates from Kunjin virus infected 293T cells (60 h post-infection) were subjected to RNA-protein co-
immunoprecipitation using CUGBP1 antibody or a control normal rabbit IgG. Co-purifying RNAs and RNAs from 10% input samples were reverse transcribed and qPCR
performed using primers to the Kunjin virus open reading frame (“KUNV ORF”) or 30 UTR (“KUNV 30 UTR”). The abundance of each KUNV RNAwas determined relative to the
10% input and normal IgG control. The average7standard deviation from three independent infections is shown.
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for sufﬁcient RNA substrate for the binding and temporary
sequestration of Dicer and AGO2 – two of the main RNAi enzy-
matic proteins with dsRNA binding domains. The extensive folding
and dsRNA-like properties of sfRNA likely play a key role in
interacting with these enzymes. Consistent with this, previous
attempts at mapping the requisite regions of sfRNA required for
RNAi suppression demonstrated that regions beyond the extended
30 most stem loop structure were important and sufﬁcient for
suppression (Schnettler et al., 2012). One possible explanation for
the partial repression of RNAi despite the binding of two impor-
tant RNAi mediators by sfRNA is that the RNA-protein interaction
may have a relatively quick dissociation rate, thus resulting in only
a temporary suppression. The large amount of sfRNA produced in
the infected cell would provide a substantial pool of reversible
inhibitor, thus providing for additional sfRNA molecules to bind
when another is released, resulting in a signiﬁcant but by no
means complete inhibition of the RNAi process. A second model
for partial RNAi suppression by sfRNA could be a relatively low or
variable afﬁnity of sfRNA for Dicer and AGO2 depending on the
organism. Differences in binding site topology between different
AGO2 proteins from different species (Kandeel and Kitade, 2013)
could also play an interesting role in sfRNA-mediated repression.
Furthermore, given that RNAi genes are among the fastest evolving
genes in mosquitoes (Bernhardt et al., 2012), one could even
speculate that differences in AGO2 binding site topology may
potentially play a role in vector competence in some instances.
While conventional models present RNAi as a ‘black and white’
cellular defense mechanism in the arms race between ﬂaviviruses
and the mosquito, adding a little bit of ‘gray’ to this model may be
biologically very relevant. A three-fold decrease in mosquito RNAi
efﬁciency in a ﬂavivirus infected cell may not seem extremely
impressive at ﬁrst glance, but one must keep in mind arboviruses
must not only replicate to high levels in the mosquito vector but
also minimize mosquito pathology in order to insure completion
of the infection/transmission cycle. Transient silencing of genes in
the RNAi pathway has been shown to increase the replication of
DENV-2 and allow the virus to better overcome midgut escape
barriers (Khoo et al., 2013). However the inclusion of a very
effective RNAi inhibitor (e.g. the Flockhouse virus B2 protein) has
also been associated with signiﬁcantly higher mosquito vector
mortality (Myles et al., 2008; Cirimotich et al., 2009). Thus a
partial repression of RNAi that balances both the needs of the
arbovirus as well as minimizes the pathological effects on the
mosquito host may be an important key to the ultimate success in
the ﬂavivirus transmission cycle.
The sfRNA that is generated from the 30 UTR of all arthropod-
associated ﬂaviviruses is emerging as an interesting multifunc-
tional non-coding RNA (Roby et al., 2014). In addition to its ability
to suppress RNAi outlined in this study, the small RNA has two
other impacts on the host cell. First, the generation of sfRNA by
XRN1 represses the activity of this exoribonuclease that plays a
major role in cellular mRNA decay (Jones et al., 2012; Moon et al.,
2012). This repression appears to feedback and shut down the
entire 50–30 mRNA decay pathway, resulting in the stabilization of
cellular mRNAs (Moon et al., 2012, 2015). This causes a major
dysregulation of cellular gene expression that may inﬂuence
cytopathology and have implications to viral pathogenesis
(Pijlman et al., 2008). The repression of XRN1 by sfRNA (Moon
et al., 2012) also accounted for the reproducible increased overall
eGFP levels compared to mock infected cells or cells infected with
a KUNV variant that was unable to produce sfRNA (Figs. 1 and 2).
Second, sfRNA serves as a binding site for several important
cellular proteins, including G3BP1, G3BP2 and CAPRIN that are
required for the efﬁcient translation of several interferon-induced
mRNAs (Bidet et al., 2014). Thus, although the overall signiﬁcance
of RNAi to antiviral activity in mammalian cells is currently under
debate (Cullen et al., 2013), sfRNA may still reduce mammalian
antiviral responses by dysregulating aspects of the interferon
pathway. Interestingly, ﬂaviviruses may not be alone among
arboviruses in having distinct roles for their 30 UTRs in mammalian
Fig. 5. Model depicting formation of sfRNA and the function of the non-coding transcript in RNAi suppression. The cellular exonuclease XRN1 generates large amounts of
non-coding sfRNA by partial decay of the ﬂavivirus genomic RNA. The accumulation of sfRNA permits sequestration of dsRNA binding proteins Dicer and AGO2, leading to a
mild suppression of the RNAi machinery in human and mosquito cells.
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versus mosquito cells. Recently the alphavirus Sindbis virus was
shown to maintain miRNA target sites in its 30 UTR which restrict
growth in dendritic cells to downgrade the overall mammalian
antiviral response and use this same region in mosquito cells to
maintain efﬁcient replication by a yet to be described mechanism
(Trobaugh et al., 2014).
There are numerous questions remaining for future studies
regarding the role of sfRNA in suppressing RNAi. It will be
interesting, for example, to demonstrate the biological importance
and evolutionary impact for the alleged need for partial RNAi
repression in ﬂavivirus biology. It will also be interesting to map
the sequences/structures required for RNAi suppression and to
determine whether and how sfRNA interacts with other less well
understood RNAi pathways (e.g. piRNA, etc.). These structures
could represent targets for antiviral therapeutics or perhaps
interesting genomic regions to manipulate to create attenuated
viruses for vaccine development. The foundation provided by this
study will hopefully fuel additional effort in this area.
Material and methods
Viruses and cells
Human 293T cells were cultured in Dulbecco's Minimal Essen-
tial Medium (DMEM; Mediatech) with 10% fetal bovine serum
(Atlas Biologicals) and 1% streptomycin/penicillin (Fisher Scienti-
ﬁc-Hyclone). Dengue virus type 2 (Jamaica 1409; GenBank:
M20558.1) was ampliﬁed on A. albopictus C6/36 mosquito cells
and titered on LLC-MK2 cells. Kunjin virus (FLSDX; Genbank:
AY274504.1) and the sfRNA-deﬁcient Kunjin virus (FLSDX
IRAΔCS3 described in Pijlman et al. (2008)) were ampliﬁed and
titered on Vero or BHK-21 cells. 293T cells were infected with
DENV-2 (MOI of 3), KUNV (MOI of 10), or sfRNA(-) KUNV (MOI of
10) by allowing virus to adsorb for 2 h at which time cells were
washed twice with warm DMEM to remove residual viral particles.
siRNA knockdown in 293T cells
All plasmids were puriﬁed using PureLinks HiPure plasmid
maxiprep kit (Life Technologies) and treated with the MiraCLEANs
endotoxin removal kit (Mirus) prior to transfection. Twenty four
hours prior to RNA collection, infected or mock infected 293T cells
were transfected with peGFP-N1 and a duplex siRNA to eGFP (50-
GCAAGCUGACCCUGAAGUUCAU) or an equal volume of water
using Lipofectamines 2000 (Life Technologies) according to the
manufacturer's protocol. Total RNA from mock infected, KUNV or
sfRNA(-) KUNV infected cells was collected at 60 h post-infection
and RNA from DENV-2 infections was collected at 4 days post-
infection using TRIzols (Life Technologies).
Mosquito infections and injections: in vivo RNAi inhibition assay
Intrathoracic inoculation of long double stranded RNA (dsRNA)
is a commonly used approach for silencing endogenous genes
within mosquitoes and has been used to effectively silence
numerous midgut speciﬁc protease genes (Brackney et al., 2008).
Therefore, using this method, we were able to examine the
potential RNAi inhibitory effects of a ﬂavivirus sfRNA in vivo.
Brieﬂy, adult female C. quinquefasciatus mosquitoes were offered
a bloodmeal containing 1107 PFU/mL of KUNV or sfRNA(-) KUNV
3–4 days post-eclosion. Engorged females were collected and
housed at 27 1C with a 14:10 light:dark cycle in order to allow
midgut infections to become established. During this time female
mosquitoes were allowed to deposit their eggs in egg-laying cups.
The generation of chymotrypsin dsRNA has been previously
described (Brackney et al., 2008). Brieﬂy, DNA templates were
generated for C. quinquefasciatus CHYMO using the following
primers: T7 CHYMO Fw 50-TAATACGACTCACTATAGGGGCTGCC-
CACTGCGAAACCGAGTA and T7 CHYMO Rv 50-TAATACGACTCACTA-
TAGGGCAGGACACGACTCCGACCTGAAC. Seven days post-infection,
mosquitoes were intrathoracically inoculated with 210 ng of
dsRNA speciﬁc for chymotrypsin or a non-speciﬁc control dsRNA
against luciferase. Following a two day incubation, whole mosqui-
toes were collected, pooled, homogenized in TRIzol reagent and
RNA extracted according to the manufacturer's instructions (Invi-
trogen). Total RNA was Turbo DNAse treated (Life Technologies)
according to manufacturer's protocol followed by phenol/chloro-
form extraction. Reverse transcriptions using random hexamers
were preformed according to manufacturer's protocol (Superscript
III First Strand Synthesis System, Invitrogen) with 500 ng of total
input RNA. qPCR was performed as described below (iQ Syber
Green Supermix) using GAPDH as a reference gene. Chymotrypsin
dsRNA injected samples were normalized to negative control
Luciferase dsRNA samples. C. quinquefasciatus qPCR primers were
as follows: CHYMO Fw 50-CAACATGGCATCGAAACTGAC; CHYMO Rv
50-GCTCCACAAAAGTGCAACG; GAPDH Fw 50-TCAAGCAGAAGGT-
CAAGGAAG; GAPDH Rv 50-GTTGTCGTACCAGGAGATGAG.
RNA analyses
RNA probes for detection of eGFP mRNA, DENV-2 sfRNA or
KUNV sfRNA were generated by internally radiolabeled T7 in vitro
transcriptions using linearized pGEM4 plasmid templates harbor-
ing the full-length 30 UTR of KUNV (FLSDX) or DENV-2 (Jamaica
1409) in the EcoRI and HindIII sites described in Moon et al.
(2012). The 782 nt eGFP open reading frame was subcloned from
peGFP-N1 into the multiple cloning site of pGEM-4 by digestion
with EcoRI and XbaI. Northern blotting to detect sfRNA from
infected 293T cells transfected with eGFP was done by separating
total RNA on formaldehyde agarose gels, transfer to a nylon
membrane and probing for the eGFP open reading frame. An
image of ethidium bromide staining of the 18S rRNA was taken
prior to transfer as a loading control. A representative northern
blot from two independent infections is shown. For sfRNA detec-
tion in infected C. quinquefasciatus, 2.5 μg total RNA isolated from
pools of 5 mosquitoes injected with a control dsRNA to luciferase
at 8 dpi with KUNV, sfRNA(-) KUNV, or blood-fed only was
separated on a 5% polyacrylamide gel, transferred to nylon
membrane, and probed with the radiolabeled antisense 30 UTR
RNA of KUNV. A representative northern blot out of three
independently collected pools of mosquitoes is shown.
To assess eGFP knockdown in 293T cells, isolated RNA from 293T
cells was treated with DpnI and EcoRI (New England Biolabs) to
linearize any remaining peGFP-N1 plasmid in the presence of RiboLock
RNase Inibitor (Thermo Scientiﬁc) for 1 h at 37 1C. Residual genomic or
plasmid DNA was removed by TURBO™ DNase (Life Technologies)
treatment at 37 1C for 30 min. Reverse transcriptions were performed
with 1 μg RNA from each sample using the Improm-II™ system
(Promega) and random hexamers according to the manufacturer's
instructions. Resulting cDNA was diluted 1:200 for qPCR detection of
eGFP using primers that spanned the siRNA target site (eGFP Fw: 50-
GACGGCGACGTAAACGGCCA; eGFP Rv: 50-CAGCTTGCCGGTGGTG-
CAGA) and GAPDH was used as a reference gene (GAPDH Fw: 50-
TCTTTTGCGTCGCCAGCCGA; GAPDH; Rv: 50-ACC-
AGGCGCCCAATACGACC). qPCR was performed using a CFX96 Real
Time PCR Detection system (Bio Rad) and iQ™ SYBRs Green Supermix
(Bio Rad). All qPCR primers had efﬁciencies between 90 and 110%. The
abundance of eGFP mRNA in each sample was determined using the
ΔΔCt method, and the relative suppression of eGFP knockdown was
calculated by normalizing eGFP expression in peGFP-N1þsiRNA
transfected samples to peGFP-N1þwater transfected samples.
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The average7standard deviation of the fold repression in eGFP
knockdown for each condition (mock, DENV-2, KUNV, or sfRNA(-)
KUNV) from two independent infections is reported. Signiﬁcance was
determined using Student's t-test.
The abundance of KUNV RNA in wild-type and sfRNA(-) KUNV
infections in C. quinquefasciatus was assessed by RT-qPCR relative
to the endogenous RPL8 transcript. Reverse transcriptions were
done as described above using random hexamers and 250 ng of
total RNA from 19 individual mosquitoes collected at 8 days post-
feeding on blood containing 1107 PFU/mL of either wild-type or
sfRNA(-) KUNV. The following primers were used for qPCR: RPL8
Fw: 50-CATCCGTGCACAGCGTAAAG; RPL8 Rv: 50-GTGCTTCAC-
GACTCCCTTCA; KUNV ORF Fw: 50-TGGACGGGGAATACCGACTTA-
GAGG; KUNV ORF Rv: 50-ACCCCAGCTGCTGCCACCTT. The average
KUNV RNA abundance7standard deviation is reported with
signiﬁcance assessed by t-test.
RNA co-immunoprecipitation and analyses
Brieﬂy, 293T cells were infected with KUNV (MOI of 5) and RNA-
protein complexes were stabilized by formaldehyde cross-linking at
60 h post-infection. Immunoprecipitations were done using rabbit
anti-Dicer (Santa Cruz Biotechnology; H-212), rat anti-Ago2 (Milli-
pore; 11A9), CUGBP-1 (3B1; Santa Cruz Biotechnology) or an equal
quantity of normal rabbit IgG (Santa Cruz Biotechnology) or normal
rat IgG (Santa Cruz Biotechnology). Equal volumes of RNA isolated
from the 10% input, IgG control, Dicer, or Ago2 immunoprecipitated
samples were reverse transcribed with random hexamer primers as
described above. The KUNV ORF or 30 UTR was detected by semi-
quantitative PCR and agarose gel electrophoresis or real-time qPCR
using the primers list above to the KUNV ORF or the following:
KUNV 30 UTR Fw: 50-GGAGACCCCGTGCCGCAAAA; KUNV 30 UTR Rv:
50-CACTGTGCCGTGTGGCTGGT. Agarose gels were stained with ethi-
dium bromide and imaged using Image Lab™ Software (Bio-Rad).
Results were conﬁrmed using RNA from an independent infection
by qPCR with a representative agarose gel presented.
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